Pharmafile Logo

Webcast: Leveraging the ASEAN opportunities

March 31, 2015 | ASEAN, market research 

Exploring the opportunities for pharma in the ASEAN region and factors to consider when conducting healthcare market research.

Home to over half a billion people, the 10 nations that make up the ASEAN region constitute the eighth largest economy in the world. With pharmaceutical sales projected to exceed US$20 billion this year, it’s an increasingly attractive and dynamic growth region for pharma marketers.

Utilising knowledge and experience garnered from conducting more than 50 projects annually across ASEAN and Emerging Markets, Associate Director PeiLi Teh and Research Manager Rachel Howard will provide you with the insights you require to successfully conduct healthcare market research in this rapidly changing and diverse region.

In this webinar we:

  • Explore why this region is an increasingly attractive and dynamic growth region for pharma
  • Investigate the key factors that will influence your ASEAN market choice
  • Identify the major considerations and top tips for conducting market research in ASEAN
  • Answer your ASEAN questions

To view this webinar please visit http://bit.ly/1sSP304 

This content was provided by Research Partnership

Company Details

 Latest Content from  Research Partnership 

Rare diseases and orphan drugs: Our experience and expertise

We have designed a complimentary infographic outlining the market opportunity as well as our experience and expertise in the growing area of rare diseases and orphan drugs, which includes links to...

Conducting research for publication video

APAC Director Pei Li Teh explains how real world insights provide an opportunity for brands to find, demonstrate and communicate their real value to patients, healthcare and society.Watch the video: https://bit.ly/2OcOWNu

Conference research case study

How conference research was used to gauge reactions to new clinical data and measure the impact of a company’s presence at a leading industry event

Portfolio analysis: Using market research to master communications across a therapeutic category

Many of us are familiar with billiard games, where two players compete to be the first to pocket all the balls on the table in a particular order.  We recently...

EphMRA round up 2018

EU Directors Angela Duffy, Richard Head and Dan coffin attended the EphMRA annual conference in Basel.

Patients’willingness to pay

Considerations when developing an appropriate pricing strategy in self-pay markets

Research Partnership launches new patient Living with Diabetes (LATAM) 2018 report

Living with Diabetes is a study conducted amongst approximately 200 Type 2 (T2D) diabetes patients in Brazil and Mexico. The report will consist of quantitative 30-minute online and qualitative telephone...

Scratching the surface: unmet needs in psoriasis

Director Mariel Metcalfe shares some key findings from a recent Living with psoriasis study conducted in Europe, which is now available to purchase.Psoriasis is a skin condition but its impact...

Shift to preventative healthcare – Opportunities for screening, diagnostics and vaccination

Across emerging markets we are seeing a shift towards prevention in healthcare policy, as governments seek to contain spiraling treatment costs.There is a growing, if long overdue, recognition among policy-makers...

Conference Live for ongoing congress performance measurement

Director John Branston discusses the benefits of a mobile approach for evaluating medical conferences year-on-year